Europe — EMA
Pankaine Spinal Heavy (Bupivacaine Hydrochloride, Anhydrous)
GNH USA supplies Pankaine Spinal Heavy (Bupivacaine), a local anesthetic for surgical anesthesia, obstetric analgesia and postoperative pain control.
Request sourcing
What is Bupivacaine Hydrochloride, Anhydrous?
Bupivacaine hydrochloride, the active ingredient in Pankaine Spinal Heavy, is a local anesthetic presented as a sterile injectable solution for spinal administration. It provides regional anesthesia for surgical procedures and obstetric analgesia, delivering prolonged sensory and motor block.
GNH USA supplies Pankaine Spinal Heavy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Bupivacaine Hydrochloride, Anhydrous used for?
Bupivacaine hydrochloride is used in the spinal route to produce regional anesthesia for various clinical situations.
- Surgical anesthesia: delivers dense sensory and motor block for lower‑body and abdominal surgeries. - Obstetric analgesia: provides effective pain relief during labor when administered spinally. - Postoperative pain control: extends analgesia after surgery, reducing the need for systemic opioids.
What are the side effects of Bupivacaine Hydrochloride, Anhydrous?
Bupivacaine may cause a range of adverse reactions, from mild to severe.
Common Side Effects: - Hypotension: drop in blood pressure due to sympathetic blockade. - Bradycardia: slowed heart rate. - Nausea and vomiting. - Urinary retention. - Post‑dural puncture headache. - Transient motor weakness.
Serious or Rare Side Effects: - Cardiac arrhythmia or cardiac arrest. - Seizures due to systemic toxicity. - Respiratory depression or apnea. - High spinal block causing respiratory compromise. - Allergic reaction or anaphylaxis. - Permanent nerve injury.
What precautions apply to Bupivacaine Hydrochloride, Anhydrous?
When using Bupivacaine spinally, several safety measures are recommended.
- Patient assessment: evaluate cardiovascular and neurologic status before injection. - Dose selection: use the lowest effective dose to achieve the desired block. - Co‑administered drugs: avoid concurrent amide local anesthetics that may increase toxicity. - Pregnancy: weigh maternal benefit against potential fetal exposure. - Allergy: screen for hypersensitivity to amide‑type anesthetics. - Store at ambient temperature: keep in original container, protect from light and moisture.
What does Bupivacaine Hydrochloride, Anhydrous interact with?
Bupivacaine can interact with other medicines, affecting safety and efficacy.
Major Interactions (Avoid): - Other amide local anesthetics: increase risk of systemic toxicity. - Beta‑adrenergic blockers: may mask early signs of toxicity. - General anesthetics (e.g., propofol, volatile agents): potentiate central nervous system depression.
Moderate Interactions (Monitor Closely): - Anticoagulants: raise the chance of spinal hematoma. - Diuretics: may exacerbate hypotension. - Opioids: can enhance respiratory depression when combined.



